Clinical Meaning of 18F-FDG PET/CT Incidental Gynecological Uptake: An 8-Year Retrospective Analysis

2021 ◽  
Vol 19 (4) ◽  
Author(s):  
Pietro Bellini ◽  
Domenico Albano ◽  
Francesco Dondi ◽  
Angelica Mazzoletti ◽  
Silvia Lucchini ◽  
...  
2009 ◽  
Vol 20 (4) ◽  
pp. 923-930 ◽  
Author(s):  
Peter Bannas ◽  
Christoph Weber ◽  
Thorsten Derlin ◽  
Jörg Lambert ◽  
Frank Leypoldt ◽  
...  

2020 ◽  
Vol 11 (10) ◽  
pp. 2864-2873 ◽  
Author(s):  
Hao Jiang ◽  
Rongjun Zhang ◽  
Huijie Jiang ◽  
Mingyu Zhang ◽  
Wei Guo ◽  
...  

2013 ◽  
Vol 54 (12) ◽  
pp. 2039-2045 ◽  
Author(s):  
V. Paidpally ◽  
A. K. Tahari ◽  
S. Lam ◽  
K. Alluri ◽  
S. Marur ◽  
...  

2014 ◽  
Vol 55 (10) ◽  
pp. 1578-1583 ◽  
Author(s):  
C. C. Riedl ◽  
E. Slobod ◽  
M. Jochelson ◽  
M. Morrow ◽  
D. A. Goldman ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 2401
Author(s):  
Alice Laffi ◽  
Marzia Colandrea ◽  
Giuseppe Buonsanti ◽  
Samuele Frassoni ◽  
Vincenzo Bagnardi ◽  
...  

Grade 3 (G3) neuroendocrine tumors (NETs) are a novel category among digestive neuroendocrine neoplasms, characterized by Ki-67 >20% and a well-differentiated morphology, presenting high intra-tumor heterogeneity. We aimed to explore the role of dual-tracer PET imaging (68Gallium (Ga)-DOTATOC and 18Fluorodeoxyglucose (FDG)) as overall survival (OS) predictor in NET G3 patients. We performed a retrospective analysis in NET G3 patients treated at our institution between 2003 and 2021. Accordingly, 30 NET G3 patients were analyzed. 68Ga-DOTA-TOC and 18F-FDG uptake were assessed by tumor/non-tumor (T-nonT) ratio. We reported a slightly better OS for patients with ≥75% concordance between 68Ga-DOTA-TOC and 18F-FDG PET/CT (p = 0.42). Among patients with discordant functional imaging, we reported a better 5-y OS rate for patients with a prevalent 68Ga-DOTATOC vs. 18F-FDG PET/CT (p = 0.016). In positive 18F-FDG PET/CT cases, we reported a better OS for <4 vs. ≥4 T/non-T ratio (p = 0.021). Among upfront-NET G3 patients with concordant exams, 5-y OS rate was 83.3% (95% CI: 27.3–97.5). Among patients with discordant exams, 5-y OS rate was 81.3% (52.5–93.5), 100% for those with prevalent receptor expression, and 50% (11.1–80.4) for those with prevalent 18F-FDG uptake. Our findings suggest that dual-tracer PET/CT can be considered as a predictor of patient outcome, able to stratify NET G3 patients with poorer prognosis.


2016 ◽  
Vol 71 ◽  
pp. S8-S9 ◽  
Author(s):  
Terence Alan Jones ◽  
Narendra Reddy ◽  
Sarah Wayte ◽  
Oludolapo Adesanya ◽  
Thomas Barber ◽  
...  

Pneumologie ◽  
2009 ◽  
Vol 63 (S 01) ◽  
Author(s):  
S Krüger ◽  
S Maschke ◽  
H Kley ◽  
T Merk ◽  
T Wibmer ◽  
...  
Keyword(s):  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  

Pneumologie ◽  
2009 ◽  
Vol 63 (S 01) ◽  
Author(s):  
S Krüger ◽  
S Maschke ◽  
H Kley ◽  
T Merk ◽  
T Wibmer ◽  
...  
Keyword(s):  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  

Sign in / Sign up

Export Citation Format

Share Document